MCCA
TMO icon

Mill Creek Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Mill Creek Capital Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.27M Sell
8,692
-42
-0.5% -$22.8K 0.09% 63
2025
Q4 		$5.06M Sell
8,734
-460
-5% -$260K 0.1% 59
2025
Q3 		$4.46M Sell
9,194
-23
-0.2% -$10.7K 0.09% 66
2025
Q2 		$3.74M Sell
9,217
-325
-3% -$136K 0.08% 69
2025
Q1 		$4.75M Buy
9,542
+1,202
+14% +$651K 0.12% 55
2024
Q4 		$4.34M Sell
8,340
-827
-9% -$455K 0.1% 59
2024
Q3 		$5.67M Sell
9,167
-4,149
-31% -$2.46M 0.14% 47
2024
Q2 		$7.36M Buy
13,316
+19
+0.1% +$10.9K 0.19% 42
2024
Q1 		$7.73M Sell
13,297
-3,497
-21% -$1.96M 0.21% 40
2023
Q4 		$8.91M Buy
16,794
+7,047
+72% +$3.41M 0.26% 34
2023
Q3 		$4.93M Sell
9,747
-114
-1% -$60.7K 0.16% 43
2023
Q2 		$5.15M Buy
9,861
+702
+8% +$379K 0.17% 43
2023
Q1 		$5.28M Sell
9,159
-11
-0.1% -$6.2K 0.19% 38
2022
Q4 		$5.05M Buy
+9,170
New +$4.86M 0.21% 36

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Mill Creek Capital Advisors's TMO Position: Q1 2026 in Review

Mill Creek Capital Advisors reduced its Thermo Fisher Scientific (TMO) stake by 0.48% in Q1 2026, selling an estimated $22.8K and leaving 8,692 shares worth $4.27M. The position accounts for 0.09% of the portfolio, ranked #63.

Mill Creek Capital Advisors first reported a position in TMO in Q4 2022 and has held it in 14 quarters since. The position peaked at $8.91M in Q4 2023. 2,605 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Mill Creek Capital Advisors held 8,692 shares of Thermo Fisher Scientific worth $4.27M as of Q1 2026.
  • Mill Creek Capital Advisors sold 42 Thermo Fisher Scientific shares in Q1 2026, an estimated $22.8K.
  • Thermo Fisher Scientific made up 0.09% of Mill Creek Capital Advisors's portfolio in Q1 2026, its #63 holding.
  • Mill Creek Capital Advisors first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 14 quarters since.
  • Mill Creek Capital Advisors's Thermo Fisher Scientific position peaked at $8.91M in Q4 2023.
  • 2,605 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Mill Creek Capital Advisors's 13F filing for Q1 2026, filed 14 May 2026.